Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study
Abstract Background Seasonal vaccination is the mainstay of human influenza prevention. Licensed influenza vaccines are regularly updated to account for viral mutations and antigenic drift and are standardised for their haemagglutinin content. However, vaccine effectiveness remains suboptimal. Neura...
Saved in:
Main Authors: | John Youhanna, Joan Puig-Barberà, Matthew S. Miller, Deborah Molrine, Monica Hadi, Shweta Bapat, Ike Iheanacho, Sophie Dodman, Tsion Fikre, Paul Swinburn, ADD-NA (Adding Neuraminidase) Delphi panel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-024-10277-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuraminidase-mediated enhancement of Streptococcus pneumoniae colonization is associated with altered mucus characteristics and distribution
by: Matthew T. Montgomery, et al.
Published: (2025-01-01) -
Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking
by: Maheswata Sahoo, et al.
Published: (2016-09-01) -
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
by: Mengyuan Liu, et al.
Published: (2025-01-01) -
Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme
by: Tambunan Usman Sumo Friend, et al.
Published: (2014-06-01) -
Genetic analysis of nucleotide sequences of neuraminidase gene of highly pathogenic avian influenza A/H5N8 virus isolates recovered in the Russian Federation in 2020
by: P. B. Akshalova, et al.
Published: (2021-11-01)